Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Vitamin A deficiency and behavioral and motor deficits in the human immunodeficiency virus type 1 transgenic rat.

June HL, Tzeng Yang AR, Bryant JL, Jones O, Royal W 3rd.

J Neurovirol. 2009 Sep;15(5-6):380-9. doi: 10.3109/13550280903350200.

2.

Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphine.

Sultana S, Li H, Puche A, Jones O, Bryant JL, Royal W.

J Neurovirol. 2010 Feb;16(1):33-40. doi: 10.3109/13550280903555712.

PMID:
20113193
3.
4.

Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat.

Lashomb AL, Vigorito M, Chang SL.

J Neurovirol. 2009 Jan;15(1):14-24. doi: 10.1080/13550280802232996. Epub 2008 Dec 9.

PMID:
19085205
5.

Neurobehavioral Abnormalities in the HIV-1 Transgenic Rat Do Not Correspond to Neuronal Hypometabolism on 18F-FDG-PET.

Reid WC, Casas R, Papadakis GZ, Muthusamy S, Lee DE, Ibrahim WG, Nair A, Koziol D, Maric D, Hammoud DA.

PLoS One. 2016 Mar 24;11(3):e0152265. doi: 10.1371/journal.pone.0152265. eCollection 2016 Mar 24.

6.

Age-related behavioural deficits in transgenic mice expressing the HIV-1 coat protein gp120.

D'hooge R, Franck F, Mucke L, De Deyn PP.

Eur J Neurosci. 1999 Dec;11(12):4398-402.

PMID:
10594667
7.

Cognitive and motor deficits associated with HIV-2(287) infection in infant pigtailed macaques: a nonhuman primate model of pediatric neuro-AIDS.

Worlein JM, Leigh J, Larsen K, Kinman L, Schmidt A, Ochs H, Ho RJ.

J Neurovirol. 2005 Feb;11(1):34-45.

PMID:
15804957
8.

Acquisition and long-term retention of spatial learning in the human immunodeficiency virus-1 transgenic rat: effects of repeated nicotine treatment.

Vigorito M, Cao J, Li MD, Chang SL.

J Neurovirol. 2013 Apr;19(2):157-65. doi: 10.1007/s13365-013-0154-1. Epub 2013 Mar 2.

9.

Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction.

Moran LM, Booze RM, Webb KM, Mactutus CF.

Exp Neurol. 2013 Jan;239:139-47. doi: 10.1016/j.expneurol.2012.10.008. Epub 2012 Oct 11.

10.

Impaired performance on a rhesus monkey neuropsychological testing battery following simian immunodeficiency virus infection.

Weed MR, Gold LH, Polis I, Koob GF, Fox HS, Taffe MA.

AIDS Res Hum Retroviruses. 2004 Jan;20(1):77-89.

PMID:
15000701
11.

Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort.

Robinson-Papp J, Byrd D, Mindt MR, Oden NL, Simpson DM, Morgello S; Manhattan HIV Brain Bank..

Arch Neurol. 2008 Aug;65(8):1096-101. doi: 10.1001/archneur.65.8.1096.

12.

A vitamin A deficient diet enhances proinflammatory cytokine, Mu opioid receptor, and HIV-1 expression in the HIV-1 transgenic rat.

Royal W 3rd, Wang H, Jones O, Tran H, Bryant JL.

J Neuroimmunol. 2007 Apr;185(1-2):29-36. Epub 2007 Feb 7.

13.

Motor skill impairment in SIV-infected rhesus macaques with rapidly and slowly progressing disease.

Marcario JK, Raymond LA, McKiernan BJ, Foresman LL, Joag SV, Raghavan R, Narayan O, Cheney PD.

J Med Primatol. 1999 Jun;28(3):105-17.

PMID:
10475111
14.
15.

Microglial activation and neurological symptoms in the SIV model of NeuroAIDS: association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changes.

Berman NE, Marcario JK, Yong C, Raghavan R, Raymond LA, Joag SV, Narayan O, Cheney PD.

Neurobiol Dis. 1999 Dec;6(6):486-98.

PMID:
10600404
16.

Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis.

Zink WE, Anderson E, Boyle J, Hock L, Rodriguez-Sierra J, Xiong H, Gendelman HE, Persidsky Y.

J Neurosci. 2002 Mar 15;22(6):2096-105.

17.

Modeling deficits in attention, inhibition, and flexibility in HAND.

Moran LM, Booze RM, Mactutus CF.

J Neuroimmune Pharmacol. 2014 Sep;9(4):508-21. doi: 10.1007/s11481-014-9539-z. Epub 2014 Apr 25.

18.

Characterization of learning and memory deficits in C57BL/6 mice infected with LP-BM5, a murine model of AIDS.

Iida R, Yamada K, Mamiya T, Saito K, Seishima M, Nabeshima T.

J Neuroimmunol. 1999 Mar 1;95(1-2):65-72.

PMID:
10229116
19.

Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.

McArthur JC, McDermott MP, McClernon D, St Hillaire C, Conant K, Marder K, Schifitto G, Selnes OA, Sacktor N, Stern Y, Albert SM, Kieburtz K, deMarcaida JA, Cohen B, Epstein LG.

Arch Neurol. 2004 Nov;61(11):1687-96. Erratum in: Arch Neurol. 2005 Jul;62(7):1110.

PMID:
15534180
20.

Evaluation of neuropsychological performance of HIV-infected patients with minor motor cognitive dysfunction treated with highly active antiretroviral therapy.

Carvalhal AS, Rourke SB, Belmonte-Abreu P, Correa J, Goldani LZ.

Infection. 2006 Dec;34(6):357-60. No abstract available.

PMID:
17180595

Supplemental Content

Support Center